Ocain Tim 4/A
4/A · ENANTA PHARMACEUTICALS INC · Filed Oct 2, 2018
Insider Transaction Report
Form 4/AAmended
Ocain Tim
Senior Vice President
Transactions
- Award
Stock Option (right to buy)
2014-01-30+70,000→ 70,000 totalExercise: $32.27Exp: 2024-01-30→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]This amendment is being filed to correct the original Form 4 filing by amending the conversion or exercise price of the derivative security reported in column 2 from "$32.43" to "$32.27". This amendment corrects an administrative error.
- [F2]25% of the shares subject to the option will vest on the first anniversary of January 30, 2014 (the "Commencement Date"), and the remaining shares will vest in twelve (12) successive and equal quarterly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Commencement Date.